EG20174A - Mixture of aliphatic alcohols of higher weight for treatment of hypercholesterolemia otheroesclerotic diseases and its obtention procedure from sugar cane wax - Google Patents

Mixture of aliphatic alcohols of higher weight for treatment of hypercholesterolemia otheroesclerotic diseases and its obtention procedure from sugar cane wax

Info

Publication number
EG20174A
EG20174A EG1493A EG1493A EG20174A EG 20174 A EG20174 A EG 20174A EG 1493 A EG1493 A EG 1493A EG 1493 A EG1493 A EG 1493A EG 20174 A EG20174 A EG 20174A
Authority
EG
Egypt
Prior art keywords
mixture
pct
hypercholesterolemia
treatment
aliphatic alcohols
Prior art date
Application number
EG1493A
Other languages
English (en)
Inventor
Abilio Laguna Grania
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Application granted granted Critical
Publication of EG20174A publication Critical patent/EG20174A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/88—Separation; Purification; Use of additives, e.g. for stabilisation by treatment giving rise to a chemical modification of at least one compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02—Monohydroxylic acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02—Monohydroxylic acyclic alcohols
    • C07C31/125—Monohydroxylic acyclic alcohols containing five to twenty-two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
EG1493A 1992-09-29 1993-01-09 Mixture of aliphatic alcohols of higher weight for treatment of hypercholesterolemia otheroesclerotic diseases and its obtention procedure from sugar cane wax EG20174A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU92107A CU22229A1 (es) 1992-09-29 1992-09-29 Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la

Publications (1)

Publication Number Publication Date
EG20174A true EG20174A (en) 1997-08-31

Family

ID=5459372

Family Applications (1)

Application Number Title Priority Date Filing Date
EG1493A EG20174A (en) 1992-09-29 1993-01-09 Mixture of aliphatic alcohols of higher weight for treatment of hypercholesterolemia otheroesclerotic diseases and its obtention procedure from sugar cane wax

Country Status (19)

Country Link
US (2) US5663156A (fr)
EP (1) EP0619802B1 (fr)
JP (1) JP3602531B2 (fr)
KR (1) KR100269844B1 (fr)
CN (3) CN1736384B (fr)
AT (1) ATE172954T1 (fr)
AU (2) AU682462B2 (fr)
BR (1) BR9305652A (fr)
CA (1) CA2124578C (fr)
CU (1) CU22229A1 (fr)
DE (1) DE69321941T2 (fr)
DK (1) DK0619802T3 (fr)
EG (1) EG20174A (fr)
ES (1) ES2125973T3 (fr)
GR (1) GR3029280T3 (fr)
HK (2) HK1032356A1 (fr)
HU (2) HU0300408D0 (fr)
RU (1) RU2163229C2 (fr)
WO (1) WO1994007830A1 (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
CU22723A1 (es) * 1997-04-02 2002-02-28 Dalmer Lab Sa Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
US5952393A (en) * 1998-02-12 1999-09-14 Sorkin, Jr.; Harlan Lee Composition for reducing serum cholesterol levels
GB9806086D0 (en) * 1998-03-20 1998-05-20 Woolcombers Group Plc Product and method of isolating same
US6596776B2 (en) * 1999-06-21 2003-07-22 Hauser, Inc. High molecular weight primary aliphatic alcohols obtained from natural products and uses thereof
US6225354B1 (en) * 1999-06-21 2001-05-01 Cholesterol Control Laboratories, Inc. High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
US6197832B1 (en) 1999-09-14 2001-03-06 Harlan Lee Sorkin, Jr. Composition for reducing serum cholesterol levels
US6355274B1 (en) * 1999-12-15 2002-03-12 Mcneil-Ppc, Inc. Encapsulated long chain alcohols
US7232574B1 (en) 1999-12-15 2007-06-19 Mcneil-Ppc, Inc. Long chain alcohols provided in edible oils
CN1091093C (zh) * 1999-12-30 2002-09-18 广东省食品工业研究所 高级脂肪醇脂肪酸酯及其用途
CN1100744C (zh) * 2000-04-30 2003-02-05 雷少华 一种由蔗蜡制取高级脂肪伯醇混合物的方法
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
US6683116B1 (en) * 2003-01-31 2004-01-27 Unigen Pharmaceuticals, Inc. Polycosanols from Ericerus pela wax
EP1503632A1 (fr) * 2002-05-02 2005-02-09 Volker Kuellmer Phytochimiques enrobes et agglomeres
US20060166951A1 (en) * 2002-05-31 2006-07-27 Archer-Daniels-Midland Company Compositions and methods for sterol isolation and purification
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
WO2003103632A1 (fr) * 2002-06-10 2003-12-18 Elan Pharma International, Ltd. Formulation de polycosanol nanoparticulaires et nouvelles combinaisons de polycosanol
KR100590620B1 (ko) * 2002-09-13 2006-06-19 박유석 화분으로부터 고급알콜을 제조하는 방법
US20060127449A1 (en) * 2003-01-28 2006-06-15 Hargrove James L Method and composition for lowering cholesterol
US7034060B2 (en) * 2003-01-31 2006-04-25 Unigen Pharmaceuticals, Inc. Polycosanols from Ericerus pela wax
US7217546B1 (en) * 2003-07-01 2007-05-15 Sami Labs Ltd Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US6890941B1 (en) * 2003-12-03 2005-05-10 Procaps S.A. Compositions containing HMG Co-A reductase inhibitors and policosanol
AP2006003832A0 (en) * 2004-01-20 2006-12-31 Panacea Biotec Ltd Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof
AP2006003834A0 (en) * 2004-01-20 2006-12-31 Panacea Biotec Ltd Novel compositions comprising higher primary alcohols and nicottinic acid and process of preparationthereof
US20050267091A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
US20050267197A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses
EP1781116A4 (fr) * 2004-06-04 2009-07-29 Horizon Science Pty Ltd Edulcorant naturel
US20060009486A1 (en) * 2004-07-07 2006-01-12 Gm Pharmaceuticals Inc. Composition and method for treatment and prevention of coronary artery disease
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7615641B2 (en) * 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
US20060020031A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
US20060020045A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Methods and compositions for treating inflammatory disorders of the gastrointestinal tract
US20060020007A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Compositions containing policosanol and biotin and their pharmaceutical uses
US20060020044A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Methods and compositions for treating or preventing macular-degeneration related disorders
US20060020043A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Methods and compositions for reducing C-reactive protein
US20060025486A1 (en) * 2004-07-27 2006-02-02 Roger Berlin Compositions containing policosanol and B vitamins and their pharmaceutical uses
US20060024383A1 (en) * 2004-07-27 2006-02-02 Roger Berlin Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses
WO2006042835A1 (fr) * 2004-10-18 2006-04-27 Dsm Ip Assets B.V. Procede de preparation d'alcools primaires aliphatiques et intermediaires associes pour la mise en oeuvre de ce procede
DE102004055858A1 (de) * 2004-11-19 2006-05-24 Clariant Gmbh Verwendung von langkettigen Alkoholen zur effektiven Senkung erhöhter Cholesterinspiegel
DE102005045829A1 (de) * 2005-09-24 2007-03-29 Clariant Produkte (Deutschland) Gmbh Mittel enthaltend langkettige Alkohole zur Suppression der Konzentrationen des C-reaktiven Proteins (CRP) im menschlichen Blut
MXPA05014086A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias antiagregantes plaquetarios combinadas para su uso en el tratamiento y prevencion de eventos vasculares de origen isquemico.
WO2007121584A1 (fr) * 2006-04-20 2007-11-01 Metabev Inc. Produit alimentaire contenant des policosanols
WO2007122636A1 (fr) * 2006-04-25 2007-11-01 Panacea Biotec Ltd Compositions pharmaceutiques contenant des acides gras à chaîne longue, et leur procédé de production
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
CN101190210B (zh) * 2006-11-23 2010-05-12 樊献俄 三十烷醇在制备抗癌药物中的应用
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
EP2129717B1 (fr) * 2007-02-23 2012-11-14 Basf Se Mélanges de n-alcools et leur utilisation
US20110124894A1 (en) * 2009-11-25 2011-05-26 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
WO2012106761A1 (fr) 2011-02-08 2012-08-16 Horizon Science Pty Ltd Extraits de sucre
CN102211976A (zh) * 2011-04-14 2011-10-12 黑龙江省科学院大庆分院 从动植物蜡中提取普利醇的方法
CN102715510A (zh) * 2012-06-18 2012-10-10 广州白云山制药股份有限公司广州白云山化学制药厂 一种天然提取物作食用功能添加剂
CN102795960B (zh) * 2012-08-08 2015-04-22 湖州圣涛生物技术有限公司 一种高纯度二十八烷醇、三十烷醇的规模化制备方法
EA031427B1 (ru) 2012-08-28 2018-12-28 Дзе Продакт Мэйкерз (Острэйлиа) Пти Лтд Способ получения экстракта, извлекаемого из сахарного тростника, и экстракт
KR101492213B1 (ko) * 2012-10-30 2015-02-16 한국식품연구원 폴리코사놀을 유효성분으로 하는 히스타민 수용체 길항제 조성물
WO2015021512A1 (fr) 2013-08-16 2015-02-19 Horizon Science Pty Ltd Extraits dérivés de canne à sucre et procédés de traitement
WO2015128829A1 (fr) 2014-02-27 2015-09-03 Tydock Pharma S.R.L. Traitement assisté par micro-ondes pour la production de mélanges enrichis en policosanol provenant de matrices de cire
CN104557458A (zh) * 2014-12-24 2015-04-29 宜宾学院 一种从青蒿素生产废弃物中提取二十八烷醇的方法
CN106187677B (zh) * 2016-07-19 2019-03-26 北京颐方生物科技有限公司 一种以蔗蜡制备高级脂肪伯醇混合物的方法及应用
CN107332573B (zh) * 2017-07-25 2021-04-13 Oppo广东移动通信有限公司 一种射频电路、天线装置及电子设备
CN110108815B (zh) * 2019-05-24 2022-01-04 江西省科学院生物资源研究所 一种用于二十八烷醇预防肝损伤效果的体外评价方法
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CN112716923B (zh) * 2021-01-13 2023-03-17 河北康泰药业有限公司 一种二十八元醇在制备治疗肺纤维化药物中的应用
CN113057941B (zh) * 2021-03-26 2022-06-17 中国林业科学研究院资源昆虫研究所 一种改善学习记忆的高级烷醇脂质体及其制备方法
CU20210060A7 (es) 2021-07-13 2023-02-13 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)
IT202100020228A1 (it) 2021-07-29 2023-01-29 Chromaleont Srl Metodo per l’estrazione di policosanoli da canapa industriale e relativa miscela.
CN115414333A (zh) * 2022-05-31 2022-12-02 湖北中古生物制药有限公司 一种多廿烷醇阿司匹林复方制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2021926A (en) * 1932-03-17 1935-11-26 Ici Ltd Treatment of waxes
GB650367A (en) * 1948-11-05 1951-02-21 Arthur Wade Improvements relating to the manufacture of therapeutic preparations
US2719858A (en) * 1952-07-31 1955-10-04 Ethyl Corp High molecular weight alcohols
US3031376A (en) * 1956-10-11 1962-04-24 Levin Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same
FR2159194A1 (en) * 1971-11-10 1973-06-22 Fabre Sa Pierre Compsns contg aspirin and sorbitol - suppression of ulcerogenic effects
US4186212A (en) * 1978-03-09 1980-01-29 Howell F Maurice Animal feed containing high molecular weight aliphatic alcohols
GB2105699B (en) * 1981-07-09 1985-06-19 Unilever Plc Preparation of materials useful as plant nutrients
US5106879A (en) * 1981-11-03 1992-04-21 Clark Lealand L Treatment for inflammatory skin disease
US5166219A (en) * 1989-11-02 1992-11-24 Lidak Pharmaceuticals Systemic anti-inflammatory treatment
CH681007A5 (fr) * 1990-10-23 1992-12-31 Nestle Sa
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la

Also Published As

Publication number Publication date
HU0300408D0 (en) 2003-04-28
US5856316A (en) 1999-01-05
CN1201731C (zh) 2005-05-18
CU22229A1 (es) 1996-01-31
CN1736384A (zh) 2006-02-22
CN1084844A (zh) 1994-04-06
BR9305652A (pt) 1996-11-19
DK0619802T3 (da) 1999-07-19
JP3602531B2 (ja) 2004-12-15
CA2124578C (fr) 2003-12-16
EP0619802A1 (fr) 1994-10-19
ES2125973T3 (es) 1999-03-16
WO1994007830A1 (fr) 1994-04-14
JPH07505414A (ja) 1995-06-15
AU711756B2 (en) 1999-10-21
CA2124578A1 (fr) 1994-04-14
HUT67607A (en) 1995-04-28
KR100269844B1 (ko) 2000-10-16
HK1087935A1 (en) 2006-10-27
CN1271577A (zh) 2000-11-01
US5663156A (en) 1997-09-02
CN1736384B (zh) 2010-05-26
GR3029280T3 (en) 1999-05-28
AU3493993A (en) 1994-04-26
DE69321941D1 (de) 1998-12-10
EP0619802B1 (fr) 1998-11-04
HU225050B1 (en) 2006-05-29
AU682462B2 (en) 1997-10-09
ATE172954T1 (de) 1998-11-15
AU5109298A (en) 1998-03-26
DE69321941T2 (de) 1999-06-10
HU9401938D0 (en) 1994-09-28
RU2163229C2 (ru) 2001-02-20
HK1032356A1 (en) 2001-07-20

Similar Documents

Publication Publication Date Title
EG20174A (en) Mixture of aliphatic alcohols of higher weight for treatment of hypercholesterolemia otheroesclerotic diseases and its obtention procedure from sugar cane wax
RU94028887A (ru) Смесь высших первичных алифатических спиртов, способ ее получения, фармацевтическая композиция на ее основе
MY121192A (en) New compounds.
ES2083881T3 (es) Procedimiento para la preparacion de agentes tensioactivos anfoteros.
DE59503363D1 (de) Wässrige fettalkoholdispersionen
ES8105264A1 (es) Un procedimiento para la preparacion de fenetanolaminas
CA2130019A1 (fr) Methode de preparation de gaz de synthese
EG20200A (en) Regioselective synthesis of 4- chloro -2- thiophenecarboxylic acid
ES8506799A1 (es) Un procedimiento para preparar un concentrado liquido de alfa-amilasa estable a los acidos y exento de actividades de amiloglucosidasa y transferasa.
Wright et al. Mevaldic acid in the biosynthesis of mevalonic acid
ES2000582A6 (es) Una composicion transparente de silicona, util para preparar composiciones transparentes para el cuidado personal
Hungerford et al. Titanium (II)-based Z-reduction of alkynes: stereo-and regio-specific Z-dideuteriation of conjugated and methylene-skipped ynes
Giorgini et al. Comments on the allergenic activity of lanolin.
NO945074L (no) 17-Alkyleton-steroider anvendelige som 5- itorer
CA2062787A1 (fr) Procede de purification de l'hemine, un nouveau derive de l'hemine et un procede conduisant a son obtention
GB1403691A (en) Liquid disinfecting toilet soap
Grossman Design and implementation of the relational view update mechanism.
JPS5462329A (en) Composition for two-phase cosmetics
Wren et al. 38. Optically active alkylsuccinic acids. Part I. Resolution of r-ethylsuccinic acid into its optical antipodes
Rob Cleansing the Food Chain
JPS562942A (en) Preparation of stabilized triethanolamine
常玉田 The Future of English
Raison 5. Chadwick (John). The Mycenae Tablets. III. With Contributions from Emmett L. Bennett, Jr., Elisabeth B. French, Lord William Taylour, Nicholas M. Verdelis, Charles K. Williams (Transactions of the American Philosophical Society, NS, Vol. 52, Part 7, 1962). Philadelphia, The American Philosophical Society, 1963
JPS5398943A (en) Preparation of 2,3-dichloro-1,4-naphthoquinone
JPS549212A (en) Preparation of hydroxycitronellal